The only accurate crypto trading system I know …

Juan Villaverde is no ordinary crypto trader. His proprietary timing algorithm has led him to rack up a series of gains of 477%, 333% and 153% on Bitcoin … It pointed the way to Cardano, at just 4 cents …Helping investors make 29 times their money.

Here's what our expert says you should buy before April 14.

AKBA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.84%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $562,184.43

Akebia Therapeutics Insider Trading History Chart

Akebia Therapeutics Share Price & Price History

^$1.36

▼ -0.0299 (-2.15%)

As of 04/19/2024 11:04 AM ET

Days: 30 | 90 | 365

The “Perfect Storm” for Gold

From Gold Safe Exchange | Ad

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

Akebia Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/29/2024	John P. Butler	CEO	Sell	46,570	$1.58	$73,580.60	2,044,580
2/29/2024	Michel Dahan	COO	Sell	8,661	$1.58	$13,684.38	706,932
2/29/2024	Nicole R Hadas	SVP	Sell	5,974	$1.58	$9,438.92	663,259
2/27/2024	John P. Butler	CEO	Sell	37,733	$1.52	$57,354.16	2,091,150
2/27/2024	Michel Dahan	COO	Sell	10,744	$1.52	$16,330.88	715,593
2/27/2024	Nicole R Hadas	SVP	Sell	7,411	$1.52	$11,264.72	669,233
2/1/2024	John P. Butler	CEO	Sell	46,489	$1.68	$78,101.52	2,128,883
2/1/2024	Steven Keith Burke	SVP	Sell	24,311	$1.68	$40,842.48	711,376
5/25/2023	Michel Dahan	COO	Sell	95,478	$1.22	$116,483.16	574,037
5/25/2023	Nicole R Hadas	SVP	Sell	63,186	$1.22	$77,086.92	524,344
5/16/2023	Steven Keith Burke	SVP	Sell	63,567	$1.07	$68,016.69	530,487
3/1/2023	David A. Spellman	CFO	Sell	7,210	$0.88	$6,344.80	510,050
3/1/2023	John P. Butler	CEO	Sell	91,868	$0.88	$80,843.84	1,568,872
3/1/2023	Michel Dahan	COO	Sell	20,412	$0.88	$17,962.56	269,515
3/1/2023	Nicole R Hadas	SVP	Sell	13,034	$0.88	$11,469.92	287,530
6/3/2022	Steven C Gilman	Director	Sell	4,567	$0.36	$1,644.12	43,430
3/1/2022	David A. Spellman	CFO	Sell	803	$2.17	$1,742.51
2/28/2022	John P. Butler	CEO	Sell	25,053	$2.15	$53,863.95
2/28/2022	Michel Dahan	COO	Sell	6,555	$2.15	$14,093.25
2/28/2022	Steven Keith Burke	SVP	Sell	7,400	$2.15	$15,910.00
2/28/2022	Violetta Cotreau	CAO	Sell	3,946	$2.15	$8,483.90
6/7/2021	Steven C. Gilman	Director	Sell	4,567	$3.32	$15,162.44	47,997

The “Perfect Storm” for Gold

From Gold Safe Exchange | Ad

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

SEC Filings (Institutional Ownership Changes) for Akebia Therapeutics (NASDAQ:AKBA)

33.92% of Akebia Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Akebia Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/18/2024	Compass Ion Advisors LLC	25,095	$46K	0.0%	N/A	0.012%
4/17/2024	Cannon Global Investment Management LLC	28,000	$51K	0.1%	N/A	0.013%
3/11/2024	Vanguard Group Inc.	7,607,472	$9.43M	0.0%	+1.1%	3.825%
3/1/2024	Goldman Sachs Group Inc.	71,201	$88K	0.0%	N/A	0.036%
2/26/2024	Virtu Financial LLC	59,479	$74K	0.0%	N/A	0.030%
2/15/2024	Vanguard Group Inc.	7,607,472	$9.43M	0.0%	+1.1%	3.825%
2/15/2024	Orchard Capital Management LLC	86,826	$0.11M	0.0%	+29.9%	0.044%
2/13/2024	Northern Trust Corp	310,368	$0.39M	0.0%	+2.7%	0.156%
2/13/2024	Goldman Sachs Group Inc.	71,201	$88K	0.0%	N/A	0.036%
2/9/2024	UBS Group AG	157,030	$0.20M	0.0%	+128.5%	0.079%
2/6/2024	Sapient Capital LLC	200,000	$0.25M	0.0%	N/A	0.101%
2/5/2024	Victory Capital Management Inc.	22,519	$28K	0.0%	-97.0%	0.011%
2/5/2024	Eagle Wealth Strategies LLC	20,017	$25K	0.0%	N/A	0.010%
1/31/2024	Federated Hermes Inc.	866,554	$1.08M	0.0%	-10.2%	0.460%
1/31/2024	Archer Investment Corp	19,800	$25K	0.0%	N/A	0.011%
1/30/2024	Mackenzie Financial Corp	23,159	$29K	0.0%	+37.6%	0.012%
1/29/2024	Sapient Capital LLC	200,000	$0.25M	0.0%	N/A	0.106%
1/16/2024	Raymond James & Associates	29,917	$37K	0.0%	+48.0%	0.016%
12/18/2023	Vanguard Group Inc.	7,521,317	$8.57M	0.0%	-3.7%	3.992%
12/6/2023	Citigroup Inc.	152,737	$0.17M	0.0%	+311,608.2%	0.081%
11/17/2023	Jacobs Levy Equity Management Inc.	1,719,061	$1.96M	0.0%	+27.7%	0.913%
11/16/2023	Creative Planning	110,428	$0.13M	0.0%	N/A	0.059%
11/14/2023	Qube Research & Technologies Ltd	121,416	$0.14M	0.0%	-72.2%	0.064%
11/13/2023	Northern Trust Corp	302,121	$0.34M	0.0%	-5.9%	0.160%
11/13/2023	Acadian Asset Management LLC	7,223,488	$8.23M	0.0%	-3.2%	3.834%
11/13/2023	FMR LLC	638,090	$0.73M	0.0%	+4.0%	0.339%
11/9/2023	Citigroup Inc.	152,737	$0.17M	0.0%	+311,608.2%	0.081%
11/8/2023	HighTower Advisors LLC	95,350	$0.11M	0.0%	+35.5%	0.051%
11/6/2023	Victory Capital Management Inc.	755,488	$0.86M	0.0%	+14.1%	0.401%
8/15/2023	XTX Topco Ltd	339,367	$0.31M	0.1%	N/A	0.183%
8/14/2023	State of Wyoming	48,207	$44K	0.0%	N/A	0.026%
8/14/2023	State Street Corp	626,050	$0.57M	0.0%	-9.6%	0.337%
8/11/2023	Renaissance Technologies LLC	3,330,727	$3.05M	0.0%	+42.4%	1.791%
8/11/2023	BlackRock Inc.	2,736,856	$2.50M	0.0%	+1.2%	1.472%
8/11/2023	Geode Capital Management LLC	1,772,977	$1.62M	0.0%	+5.4%	0.954%
8/11/2023	JPMorgan Chase & Co.	37,903	$35K	0.0%	-53.5%	0.020%
8/11/2023	Northern Trust Corp	320,958	$0.29M	0.0%	-13.8%	0.173%
8/7/2023	Acadian Asset Management LLC	7,460,353	$6.82M	0.0%	-0.3%	4.012%
8/3/2023	Mackenzie Financial Corp	27,199	$25K	0.0%	-34.3%	0.015%
7/27/2023	Victory Capital Management Inc.	661,898	$0.61M	0.0%	+156.8%	0.356%
7/27/2023	Virtu Financial LLC	50,633	$46K	0.0%	-48.3%	0.027%
7/27/2023	CWA Asset Management Group LLC	49,000	$45K	0.0%	+69.0%	0.026%
7/19/2023	Eudaimonia Partners LLC	27,144	$25K	0.0%	+123.5%	0.015%
5/18/2023	JPMorgan Chase & Co.	81,547	$45K	0.0%	+1,916.5%	0.044%
5/16/2023	Jane Street Group LLC	46,193	$26K	0.0%	-91.6%	0.025%
5/16/2023	State Street Corp	692,836	$0.39M	0.0%	+21.1%	0.373%
5/15/2023	Two Sigma Securities LLC	138,037	$77K	0.0%	+64.8%	0.074%
5/15/2023	Price T Rowe Associates Inc. MD	105,500	$60K	0.0%	-36.8%	0.057%
5/15/2023	Alerce Investment Management L.P.	16,205,119	$9.08M	12.0%	+7.4%	8.716%
5/12/2023	Renaissance Technologies LLC	2,338,500	$1.31M	0.0%	-19.0%	1.258%
5/12/2023	BlackRock Inc.	2,703,523	$1.52M	0.0%	-7.5%	1.454%
5/12/2023	Bank of America Corp DE	193,459	$0.11M	0.0%	+44.6%	0.104%
5/12/2023	Mirabella Financial Services LLP	140,604	$1.83M	0.3%	N/A	0.076%
5/12/2023	HRT Financial LP	148,681	$83K	0.0%	N/A	0.080%
5/12/2023	UBS Group AG	87,975	$49K	0.0%	+49.7%	0.047%
5/12/2023	Charles Schwab Investment Management Inc.	79,804	$45K	0.0%	-39.7%	0.043%
5/12/2023	HighTower Advisors LLC	70,350	$40K	0.0%	+18.4%	0.038%
5/11/2023	Icon Wealth Partners LLC	50,000	$28K	0.0%	N/A	0.027%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	302,977	$0.17M	0.0%	+152.4%	0.163%
5/2/2023	Victory Capital Management Inc.	257,744	$0.14M	0.0%	+1,200.3%	0.140%
5/1/2023	Virtu Financial LLC	97,854	$55K	0.0%	N/A	0.053%
2/15/2023	Public Employees Retirement System of Ohio	149,945	$87K	0.0%	-18.5%	0.082%
2/15/2023	Millennium Management LLC	1,342,422	$0.78M	0.0%	-61.4%	0.730%
2/15/2023	Alerce Investment Management L.P.	15,090,119	$8.71M	10.0%	+224.3%	8.203%
2/14/2023	Two Sigma Investments LP	374,289	$0.22M	0.0%	-30.3%	0.203%
2/13/2023	Renaissance Technologies LLC	2,886,227	$1.67M	0.0%	-4.3%	1.569%
2/13/2023	Geode Capital Management LLC	1,682,498	$0.97M	0.0%	+3.7%	0.915%
2/10/2023	Bank of America Corp DE	133,764	$77K	0.0%	-52.5%	0.073%
2/10/2023	Orchard Capital Management LLC	66,826	$39K	0.0%	-73.5%	0.036%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	120,053	$69K	0.0%	-76.5%	0.065%
2/8/2023	UBS Group AG	58,755	$34K	0.0%	-55.5%	0.032%
11/15/2022	Public Employees Retirement System of Ohio	183,979	$58K	0.0%	N/A	0.100%
11/15/2022	Jacobs Levy Equity Management Inc.	2,042,816	$0.65M	0.0%	+162.7%	1.110%
11/15/2022	Two Sigma Investments LP	537,361	$0.17M	0.0%	+151.6%	0.292%
11/15/2022	Vanguard Group Inc.	13,182,865	$4.17M	0.0%	-18.9%	7.166%
11/15/2022	Price T Rowe Associates Inc. MD	166,900	$54K	0.0%	+254.4%	0.091%
11/15/2022	Marshall Wace LLP	314,316	$0.10M	0.0%	N/A	0.171%
11/15/2022	Federated Hermes Inc.	1,800,536	$0.57M	0.0%	-9.5%	0.979%
11/15/2022	BlackRock Inc.	4,286,956	$1.36M	0.0%	-1.2%	2.330%
11/14/2022	Renaissance Technologies LLC	3,016,427	$0.95M	0.0%	+103.5%	1.640%
11/14/2022	Ergoteles LLC	165,237	$52K	0.0%	-80.5%	0.090%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	510,102	$0.16M	0.0%	+124.9%	0.277%
11/10/2022	Dimensional Fund Advisors LP	627,549	$0.20M	0.0%	-19.8%	0.341%
10/26/2022	Allspring Global Investments Holdings LLC	242,866	$76K	0.0%	+43.8%	0.132%
10/26/2022	Wipfli Financial Advisors LLC	200,000	$63K	0.0%	N/A	0.109%
9/16/2022	Federated Hermes Inc.	1,989,467	$0.70M	0.0%	-2.0%	1.082%
8/18/2022	Goldman Sachs Group Inc.	341,546	$0.12M	0.0%	-62.1%	0.186%
8/17/2022	Parallax Volatility Advisers L.P.	109,683	$39K	0.0%	-68.2%	0.060%
8/15/2022	AQR Capital Management LLC	862,168	$0.30M	0.0%	+367.4%	0.469%
8/15/2022	State Street Corp	573,876	$0.20M	0.0%	-95.0%	0.312%
8/15/2022	Millennium Management LLC	5,354,175	$1.89M	0.0%	+65.8%	2.912%
8/13/2022	Renaissance Technologies LLC	1,482,300	$0.52M	0.0%	+47.7%	0.806%
8/12/2022	Northern Trust Corp	360,526	$0.13M	0.0%	-78.5%	0.196%
8/12/2022	FMR LLC	621,244	$0.22M	0.0%	+177.3%	0.338%
8/12/2022	BNP Paribas Arbitrage SA	90,540	$32K	0.0%	+123.7%	0.049%
8/12/2022	Franklin Resources Inc.	82,473	$29K	0.0%	-32.6%	0.045%
8/11/2022	UBS Group AG	130,652	$46K	0.0%	-83.0%	0.071%
8/10/2022	Principal Financial Group Inc.	414,392	$0.15M	0.0%	+124.1%	0.226%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	226,770	$80K	0.0%	-51.9%	0.124%
7/29/2022	Russell Investments Group Ltd.	225,640	$78K	0.0%	-11.8%	0.123%

Data available starting January 2016

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent patients. It offers Auryxia, a ferric citrate that is used to control the serum phosphorus levels in adult patients with DD-CKD on dialysis; and the treatment of iron deficiency anemia in adult patients with CKD not on dialysis. The company's product pipeline includes AKB-9090, a drug targeting critical-care indications; and AKB-10108, a drug targeting conditions related to premature birth. It has collaboration agreements with Mitsubishi Tanabe Pharma Corporation for the development and commercialization of vadadustat in Japan and other Asian countries, as well as research and license agreement with Janssen Pharmaceutica NV for the development and commercialization of hypoxia-inducible factor prolyl hydroxylase targeted compounds worldwide. Akebia Therapeutics, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $1.36

$1.33

$1.38

50 Day Range

MA: $1.60

$1.35

$2.24

52 Week Range

Now: $1.36

$0.59

$2.48

Volume

461,199 shs

Average Volume

4,347,710 shs

Market Capitalization

$284.76 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.79

Who are the company insiders with the largest holdings of Akebia Therapeutics?: Akebia Therapeutics' top insider shareholders include:
John P Butler (CEO)
Michel Dahan (COO)
Steven Keith Burke (SVP)
Nicole R Hadas (SVP)
David A Spellman (CFO)
Steven C Gilman (Director)
Learn More about top insider investors at Akebia Therapeutics.
Who are the major institutional investors of Akebia Therapeutics?: Akebia Therapeutics' top institutional investors include:
Cannon Global Investment Management LLC — 0.01%
Compass Ion Advisors LLC — 0.01%
Learn More about top institutional investors of Akebia Therapeutics stock.
Which institutional investors are buying Akebia Therapeutics stock?: Within the last quarter, AKBA stock was purchased by institutional investors including:
Cannon Global Investment Management LLC
Compass Ion Advisors LLC